Potential changes to MRLs under EC Regulation 396/2005
Since September 2008 all statutory MRLs have been set on an EC-wide basis under Regulation 396/2005. Proposals to set, modify or delete MRLs in Regulation 396/2005 are under regular consideration. These proposals are based on EFSA Opinions and are subject to votes in the EU Standing Committee on the Food Chain and Animal Health (Residues section). Proposals for lowered MRLs are notified to the World Trade Organisation (WTO) following the first indicative vote to allow third countries to raise any points of difficulty. Once all concerns have been addressed a formal vote is taken by the Committee, after which the proposal is adopted provided the necessary majority of member states is secured and following scrutiny by the European Parliament and Council.
We welcome any comments on these proposals. If possible, please submit these well in advance of discussions in the Standing Committee to Russell Wedgbury (russell.wedgbury@hse.gsi.gov.uk ).
The next Standing Committee meeting is scheduled for 11 & 12 June 2012.
| Actives | Possible applicable date | SANCO Proposal/Draft Regulation | Further details |
| 2,4 DB
dimethomorph
indoxacarb
pyraclostrobin | To be discussed at June 2012 Standing Committee meeting. Further details to be provided following the June meeting. | Sanco 10392/2012 (document not yet available) Annex. | Proposal includes MRLs reviewed under Article 12 of Regulation 396/2005. EFSA Opinions |
| acetamiprid
clodinafop
clomazone
diuron
ethalfluralin
ioxynil
iprovalicarb
maleic hydrazide
mepanipyrim
metconazole
prosulfocarb
tepraloxydim | To be discussed at June 2012 Standing Committee meeting. Further details to be provided following the June meeting. | Sanco 10376/2012 (document not yet available) Annex. | Proposal includes MRLs reviewed under Article 12 of Regulation 396/2005. EFSA Opinions |
| cyromazine
fenpropidin
formetanate
oxamyl
tebuconazole | To be discussed at June 2012 Standing Committee meeting. Further details to be provided following the June meeting. | Sanco 12783/2011 Annex. | Proposal includes active substances with expired essential uses. MRLs are reduced to LOD unless substantive levels needed based on Codex levels or import tolerances. Enters into force 20 days following publication in the Official Journal and shall apply 6 months later. EFSA Opinions |
| Revision to Annex I of Regulation 396/2005 - list of food and feed products to which MRLs apply | To be discussed at June 2012 Standing Committee meeting. Further details to be provided following the June meeting. | Sanco 12206/2010 | Proposal makes additions and modifications to the examples of related varieties or other products listed in Annex I of Regulation 396/2005. Enters into force 20 days following publication in the Official Journal. |
| bifenazate
captan
cyprodinil
fluopicolide
hexythiazox
isoprothiolane
metaldehyde
oxadixyl
phosmet | Publication of amending Regulation likely in July/August 2012 | Sanco 10202/2012 Annex. | Proposal voted through at March 2012 Standing Committee meeting. Awaiting publication following European Parliament and Council scrutiny. Voted proposal includes MRLs to address new and changed uses. Enters into force 20 days following publication in the Official Journal. |
| acephate
alachlor
anilazine
azocyclotin and cyhexatin
benfuracarb
butylate
captafol
carbaryl
carbofuran
carbosulfan
chlorfenapyr
chlorthal-dimethyl
chlorthiamid
diazinon
dichlobenil
dicofol
dimethipin
diniconazole
disulfoton
fenitrothion
flufenzin
furathiocarb
hexaconazole
lactofen
mepronil
methamidophos
methoprene
monocrotophos
monuron
oxycarboxin
oxydemeton-methyl
parathion-methyl
phorate
phosalone
procymidone
profenofos
propachlor
quinclorac
quintozene
tolylfluanid
trichlorfon
tridemorph
trifluralin | Publication of amending Regulation likely in July/August 2012 | Sanco 10691/2011 Annex. | Proposal voted through at March 2012 Standing Committee meeting. Awaiting publication following European Parliament and Council scrutiny. Voted proposal includes lowered MRLs for non approved substances for which consumer concerns were identified and/or for which authorisations were withdrawn. MRLs are reduced with the exception of levels that are deemed to be safe based on Codex levels or import tolerances. Enters into force one day following publication in the Official Journal and shall apply 6 months later. |
| bifenazate
bifenthrin
boscalid
cadusafos
chlorantraniliprole
chlorothalonil
clothianidin
cyproconazole deltamethrin
dicamba
difenoconazole
dinocap
etoxazole
fenpyroximate
flubendiamide
fludioxonil
glyphosate
meptyldinocap
metalaxyl-m
novaluron
thiamethoxam
triazophos | Publication of amending Regulation likely in June/July 2012 | Sanco 12226/2011 Annex. | Proposal voted through at February 2012 Standing Committee meeting. Awaiting publication following European Parliament and Council scrutiny. Voted proposals includes MRLs to address new and changed uses. Enters into force 20 days following publication in the Official Journal. |
Contact: Russell Wedgbury; tel 01904 455780; fax 01904 455733; e-mail russell.wedgbury@hse.gsi.gov.uk
A list of published Commission Regulations is available on our Published Regulations page.
[back to top]
